Viruses are able to redirect the functioning of cells in order to infect them. Inspired by their mode of action, scientists from the CNRS and Université de Strasbourg have designed a “chemical virus” that can cross the double lipid layer that surrounds cells, and then disintegrate in the intracellular medium in order to release active compounds.
To achieve this, the team used two polymers they had designed, which notably can self-assemble or dissociate, depending on the conditions. This work, the result of collaborative efforts by chemists, biologists and biophysicists, is published in the 1st September issue of Angewandte Chemie International Edition.
Biotechnological advances have offered access to a wealth of compounds with therapeutic potential. Many of these compounds are only active inside human cells but remain unusable because the lipid membrane surrounding these cells is a barrier they cannot cross. The challenge is therefore to find transfer solutions that can cross this barrier.
By imitating the ability of viruses to penetrate into cells, chemists in the Laboratoire de Conception et Application de Molécules Bioactives (CNRS/Université de Strasbourg) sought to design particles capable of releasing macromolecules that are only active inside cells. To achieve this, these particles must comply with several, often contradictory, constraints. They must remain stable in the extracellular medium, they must be able to bind to the cells so that they be internalized, but they must be more fragile inside the cells so that they can release their content.
Using two polymers designed by the team, the scientists succeeded in creating a “chemical virus” that meets the conditions necessary for the direct delivery of active proteins into cells.
In practice, the first polymer (pGi-Ni2+) serves as a substrate for the proteins that bind to it. The second, recently patented polymer (?PEI), encapsulates this assembly thanks to its positive charges, which bind to the negative charges of pGi-Ni2+. The particles obtained (30-40 nanometers in diameter) are able to recognize the cell membrane and bind to it. This binding activates a cellular response: the nanoparticle is surrounded by a membrane fragment and enters the intracellular compartment, called the endosome. Although they remain stable outside the cell, the assemblies are attacked by the acidity that prevails within this new environment. Furthermore, this drop in pH allows the ?PEI to burst the endosome, releasing its content of active compounds.
Thanks to this assembly, the scientists were able to concentrate enough active proteins within the cells to achieve a notable biological effect. Thus by delivering a protein called caspase 3 into cancer cell lines, they succeeded in inducing 80% cell death1.
The in vitro results are encouraging, particularly since this “chemical virus” only becomes toxic at a dose ten times higher than that used during the study. Furthermore, preliminary results in the mouse have not revealed any excess mortality. However, elimination by the body of the two polymers remains an open question. The next stage will consist in testing this method in-depth and in vivo, in animals. In the short term, this system will serve as a research tool to vectorize2 recombinant and/or chemically modified proteins into cells. In the longer term, this work could make it possible to apply pharmaceutical proteins to intracellular targets and contribute to the development of innovative drugs.
Read more: Imitating viruses to deliver drugs to cells
The Latest on: Imitating viruses to deliver drugs to cells
via Google News
The Latest on: Imitating viruses to deliver drugs to cells
- The Weekend Jolton August 2, 2022 at 5:00 pm
Once upon a time in the City of Brotherly Love, great men wrote on parchment a testimony to liberty and the natural state of those living in America — and indeed of all peoples living in all ...
- Stock News & Analysison August 1, 2022 at 5:00 pm
It's a pressing matter: a chef's salad of European crises is about to send the price of oil skyrocketing once more. Olive oil, that is. Olive... When Dara Khosrowshahi sits down for dinner tonight ...
- T-cells more important in the fight against the COVID-19 virus than initially thoughton August 1, 2022 at 7:54 am
A COVID-19 vaccine that specifically instructs the immune system to produce T-cells rather than antibodies is shown to provide good protection in a mouse model, Leiden University Medical Center (LUMC) ...
- This Drug Can Help Monkeypox. But The FDA Makes It Hard to Get.on July 30, 2022 at 8:22 pm
YUKI IWAMURA/AFP via GettyThe government agency charged with helping Americans obtain treatment for monkeypox may once again be allowing red tape to stand between doctors and the treatment their ...
- Deal reached for generic drug to prevent HIV infectionon July 28, 2022 at 11:32 pm
A deal has been reached to allow for distribution of a low-cost generic version of a long-term preventative treatment against HIV in low-income countries where most of the world's infections occur, ...
- COVID-19: New energy for flagging immune cellson July 28, 2022 at 3:54 am
In severe COVID-19 patients, metabolism produces insufficient amounts of certain energy-rich compounds called ketone bodies. However, these energy carriers are needed by two important cell types in ...
- A Short History Of AI, And Why It’s Heading In The Wrong Directionon July 24, 2022 at 5:00 pm
Sir Winston Churchill often spoke of World War 2 as the “Wizard War”. Both the Allies and Axis powers were in a race to gain the electronic advantage over each other on the battlefield.
- Host Cell Proteins That Aid Lassa Virus & A Way to Stop One of Themon July 24, 2022 at 7:16 am
Lassa virus infections are asymptomatic in about 80 percent of people. But the virus also causes Lassa fever (LF), which is a hemorrhagic fever that can be | Microbiology ...
- Connected Drug Delivery Devices Market is expected to reach US$ 1.6 Billion by 2028on July 21, 2022 at 5:03 am
Pages Report]According to the analyst of Future Market Insights (FMI), the leading manufacturers of connected drug delivery devices are focusing collaboration with the software companies to assess the ...
- LabCorp (LH) to Report Q2 Earnings: What's in the Cards?on July 20, 2022 at 6:16 am
which is anticipated to deliver $350 million in savings over the next three years. The new initiative is expected to have contributed to the company’s second-quarter margin. Covance Drug Development ...
via Bing News